Brief: Metacrine Inc Cash And Cash Equivalents Were $52.8 Million As Of Sept. 30
14/11/2022 23:02
Nov 14 (Reuters) - Metacrine Inc MTCR.O :
* METACRINE INC - CASH AND CASH EQUIVALENTS WERE $52.8
MILLION AS
OF SEPTEMBER 30, 2022
* METACRINE INC - NET LOSS WAS $5.5 MILLION FOR THE THREE
MONTHS
ENDED SEPTEMBER 30, 2022
* METACRINE INC - BELIEVES IT HAS SUFFICIENT CAPITAL TO FUND
ITS
CURRENT OPERATING PLAN THROUGH AT LEAST 2023
Further company coverage: MTCR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metacrine
See all newsMetacrine Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Brief: Metacrine Inc- On Jan 31, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Metacrine CEO Preston Klassen Was Terminated From All Positions